Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04423848 · ClinicalTrials.gov registry record · NA
Home Hospital for Lymphoma
A NA study, sponsored by Massachusetts General Hospital.
- Terminated
- Registry status
- NA
- Development phase
- 3
- Enrollment target
NCT04423848: Clinical Trial NA study, sponsored by Massachusetts General Hospital.
NCT04423848 is a NA study that was terminated before completion, run by Massachusetts General Hospital. The registered enrollment target is 3 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04423848, a NA study, was terminated before completion, sponsored by Massachusetts General Hospital.
- TERMINATED
- Registry status
- NA
- Development phase
- 3 participants
- Enrollment target
Study Summary
The goal of this research is to evaluate an intervention, which the investigators call "Home Hospital for Lymphoma," that involves remote patient monitoring and home-based supportive care for patients hospitalized with lymphoma at Massachusetts General Hospital.
Interventions
- OTHER Home Hospital for Lymphoma
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2020-06-01 |
| Est. Completion | 2021-01-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04423848
The ClinicalTrials.gov registry entry for NCT04423848 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Home Hospital for Lymphoma is the first listed.
NCT04423848 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04423848 about?
NCT04423848 is a clinical study titled "Home Hospital for Lymphoma". The goal of this research is to evaluate an intervention, which the investigators call "Home Hospital for Lymphoma," that involves remote patient monitoring and home-based supportive care for patients hospitalized with lymphoma at Massachusetts General Hospital.
What is the current status of trial NCT04423848?
This trial is currently terminated. It is a NA study. The enrollment target is 3 participants. The study started on 2020-06-01. Estimated completion is 2021-01-30.
What interventions are being tested in trial NCT04423848?
The interventions under investigation include: Home Hospital for Lymphoma (OTHER).
Who is sponsoring clinical trial NCT04423848?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.